✦ LIBER ✦

Market access of biosimilars: not only a cost issue

✍ Scribed by S. Simoens; G. Verbeken; I. Huys

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biosimilars and market access: a questio

✍ Steven Simoens, Gilbert Verbeken, Isabelle Huys 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 105 KB

Mutations and chromosomal rearrangements

✍ Salmoiraghi, Silvia; Guinea Montalvo, Marie Lorena; D’Agostini, Elena; Amicarell 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 384 KB

VIRULENCE NOT ONLY COSTS BUT ALSO BENEFI

✍ Sarah Franziska Bryner; Daniel Rigling 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

Externalism and A Priori Knowledge of th

✍ Maria Lasonen-Aarnio 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Gaining a product orphan designation is

✍ Gisby, M.; Bache, G.; Paglia, B.; Patel, V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Accessibility is gold, mobility is not:

📂 Article 📅 2012 🏛 Pion Ltd. 🌐 English ⚖ 399 KB